Download presentation
Presentation is loading. Please wait.
1
Securing the cure in resectable lung cancer
Presented By Suresh Senan at 2017 ASCO Annual Meeting
2
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Disclosures Presented By Suresh Senan at 2017 ASCO Annual Meeting
3
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Resectable NSCLC Presented By Suresh Senan at 2017 ASCO Annual Meeting
4
Treatment of stage I NSCLC: NCDB1
Presented By Suresh Senan at 2017 ASCO Annual Meeting
5
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Treatment of stage III NSCLC (TNM7) <br />Patterns of care in the Netherlands Cancer Registry1,2 Presented By Suresh Senan at 2017 ASCO Annual Meeting
6
Adjuvant therapy in resected NSCLC1
Presented By Suresh Senan at 2017 ASCO Annual Meeting
7
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Slide 7 Presented By Suresh Senan at 2017 ASCO Annual Meeting
8
EGFR mutated NSCLC: adjuvant
Presented By Suresh Senan at 2017 ASCO Annual Meeting
9
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Abstracts Presented By Suresh Senan at 2017 ASCO Annual Meeting
10
ADJUVANT study design (NCT01405079)
Presented By Suresh Senan at 2017 ASCO Annual Meeting
11
ADJUVANT Primary endpoint: DFS
Presented By Suresh Senan at 2017 ASCO Annual Meeting
12
ADJUVANT: Demographics (ITT population)
Presented By Suresh Senan at 2017 ASCO Annual Meeting
13
ADJUVANT trial: Comments
Presented By Suresh Senan at 2017 ASCO Annual Meeting
14
EGFR TKI Adjuvant Trials (in EGFRmut populations)
Presented By Suresh Senan at 2017 ASCO Annual Meeting
15
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Abstracts Presented By Suresh Senan at 2017 ASCO Annual Meeting
16
Management of Isolated Local-Regional Failure after SABR
Presented By Suresh Senan at 2017 ASCO Annual Meeting
17
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Post SABR follow-up Presented By Suresh Senan at 2017 ASCO Annual Meeting
18
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Slide 18 Presented By Suresh Senan at 2017 ASCO Annual Meeting
19
Post SABR salvage treatments
Presented By Suresh Senan at 2017 ASCO Annual Meeting
20
SABR: Actuarial Patterns of Failure
Presented By Suresh Senan at 2017 ASCO Annual Meeting
21
Post-SABR isolated recurrences
Presented By Suresh Senan at 2017 ASCO Annual Meeting
22
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Slide 22 Presented By Suresh Senan at 2017 ASCO Annual Meeting
23
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Abstracts Presented By Suresh Senan at 2017 ASCO Annual Meeting
24
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Slide 24 Presented By Suresh Senan at 2017 ASCO Annual Meeting
25
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Overall survival Presented By Suresh Senan at 2017 ASCO Annual Meeting
26
Presented By Suresh Senan at 2017 ASCO Annual Meeting
NVALT 11: Endpoints Presented By Suresh Senan at 2017 ASCO Annual Meeting
27
Presented By Suresh Senan at 2017 ASCO Annual Meeting
<br />NVALT 11 (Primary endpoint) : Brain metastases (BM) and neurological symptoms Presented By Suresh Senan at 2017 ASCO Annual Meeting
28
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Slide 28 Presented By Suresh Senan at 2017 ASCO Annual Meeting
29
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Slide 29 Presented By Suresh Senan at 2017 ASCO Annual Meeting
30
Presented By Suresh Senan at 2017 ASCO Annual Meeting
Conclusions Presented By Suresh Senan at 2017 ASCO Annual Meeting
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.